Bristol-Myers Squibb Company (BMY) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
ROUTE 206 AND PROVINCE LINE ROAD PRINCETON, NJ 08543 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 12,280 | 9,253 | 16,966 | 15,831 | 15,393 | 8,884 | |||
| Cash and cash equivalents | 11,464 | 9,123 | 13,979 | 14,546 | 12,346 | 6,911 | |||
| Short-term investments | 816 | 130 | 2,987 | 1,285 | 3,047 | 1,973 | |||
| Receivables | 10,921 | 9,886 | 9,369 | 8,501 | 7,685 | 5,965 | |||
| Inventory, net of allowances, customer advances and progress billings | 2,662 | 2,339 | 2,095 | 2,074 | 4,293 | 1,195 | |||
| Inventory | 2,662 | 2,339 | 2,095 | 2,074 | 4,293 | 1,195 | |||
| Other current assets | 5,907 | 5,795 | 4,832 | 3,786 | 1,983 | 1,116 | |||
| Total current assets: | 31,770 | 27,273 | 33,262 | 30,192 | 29,354 | 17,160 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 429 | ||||||||
| Property, plant and equipment | 6,646 | 6,255 | 6,049 | 5,886 | 6,252 | 5,027 | |||
| Long-term investments and receivables | 364 | 433 | 767 | 1,775 | |||||
| Long-term investments | 364 | 433 | 767 | 1,775 | |||||
| Intangible assets, net (including goodwill) | 48,241 | 57,008 | 63,029 | 73,790 | 86,457 | 7,629 | |||
| Goodwill | 21,169 | 21,149 | 20,502 | 20,547 | 22,488 | 6,538 | |||
| Intangible assets, net (excluding goodwill) | 27,072 | 35,859 | 42,527 | 53,243 | 63,969 | 1,091 | |||
| Deferred income tax assets | 2,768 | 1,344 | 1,439 | 1,161 | ✕ | ||||
| Other noncurrent assets | 5,370 | 4,940 | 5,535 | 7,019 | 6,604 | 2,024 | |||
| Other undisclosed noncurrent assets | 510 | 942 | |||||||
| Total noncurrent assets: | 63,389 | 69,547 | 76,052 | 88,289 | 100,590 | 17,826 | |||
| TOTAL ASSETS: | 95,159 | 96,820 | 109,314 | 118,481 | 129,944 | 34,986 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,259 | 3,040 | 2,949 | 2,713 | 2,445 | 8,779 | |||
| Taxes payable | ✕ | ✕ | ✕ | 398 | |||||
| Accounts payable | 3,259 | 3,040 | 2,949 | 2,713 | 2,445 | 1,892 | |||
| Accrued liabilities | 6,489 | ||||||||
| Debt | 3,119 | 4,264 | 4,948 | 2,340 | 3,346 | 1,703 | |||
| Other liabilities | 15,884 | 14,586 | 13,971 | 14,027 | 12,513 | ||||
| Other undisclosed current liabilities | 172 | ||||||||
| Total current liabilities: | 22,262 | 21,890 | 21,868 | 19,080 | 18,304 | 10,654 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 36,653 | 35,056 | 39,605 | 48,336 | 43,387 | 5,646 | |||
| Long-term debt, excluding current maturities | 36,653 | 35,056 | 39,605 | 48,336 | 43,387 | 5,646 | |||
| Liabilities, other than long-term debt | 6,759 | 8,756 | 11,835 | 13,183 | 16,555 | 4,109 | |||
| Accounts payable and accrued liabilities | 3,043 | ||||||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 18 | ||
| Deferred income tax liabilities | 338 | 2,166 | 4,501 | 5,407 | 6,454 | ✕ | |||
| Other liabilities | 6,421 | 6,590 | 7,334 | 7,776 | 10,101 | 1,048 | |||
| Other undisclosed noncurrent liabilities | 450 | ||||||||
| Total noncurrent liabilities: | 43,412 | 43,812 | 51,440 | 61,519 | 59,942 | 10,205 | |||
| Total liabilities: | 65,674 | 65,702 | 73,308 | 80,599 | 78,246 | 20,859 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 29,430 | 31,061 | 35,946 | 37,822 | 51,598 | 14,031 | |||
| Common stock | 292 | 292 | 292 | 292 | 221 | ||||
| Treasury stock, value | (43,766) | (38,618) | (31,259) | (26,237) | (25,357) | (19,574) | |||
| Additional paid in capital | 45,684 | 45,165 | 44,361 | 44,325 | 43,709 | 2,081 | |||
| Accumulated other comprehensive loss | (1,546) | (1,281) | (1,268) | (1,839) | (1,520) | (2,762) | |||
| Retained earnings | 28,766 | 25,503 | 23,820 | 21,281 | 34,474 | 34,065 | |||
| Other undisclosed equity, attributable to parent | 292 | ||||||||
| Equity, attributable to noncontrolling interest | 55 | 57 | 60 | 60 | 100 | 96 | |||
| Total equity: | 29,485 | 31,118 | 36,006 | 37,882 | 51,698 | 14,127 | |||
| TOTAL LIABILITIES AND EQUITY: | 95,159 | 96,820 | 109,314 | 118,481 | 129,944 | 34,986 | |||
Income Statement (P&L) ($ in millions)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 45,006 | 46,159 | 46,385 | 42,518 | 26,145 | 22,561 | ||
| Cost of revenue | (19,495) | (21,123) | (19,243) | (30,585) | (10,151) | (6,547) | ||
| Cost of goods and services sold | (10,693) | (10,137) | (9,940) | (11,773) | (8,078) | (6,547) | ||
| Other undisclosed gross profit | 18,812 | 2,073 | ||||||
| Gross profit: | 25,511 | 25,036 | 27,142 | 30,745 | 18,067 | 16,014 | ||
| Operating expenses | (17,071) | (17,323) | (19,044) | (18,804) | (11,019) | (10,896) | ||
| Operating income (loss): | 8,440 | 7,713 | 8,098 | 11,941 | 7,048 | 5,118 | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 1,158 | (576) | 720 | 2,314 | (938) | 850 | ||
| Interest and debt expense | (1,166) | (266) | (281) | (1,420) | (656) | (183) | ||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (19,706) | (479) | 183 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 8,432 | 6,871 | 8,537 | (6,871) | 4,975 | 5,968 | ||
| Income from equity method investments | ||||||||
| Other undisclosed income (loss) from continuing operations before income taxes | 8 | 842 | (439) | |||||
| Income (loss) from continuing operations before income taxes: | 8,440 | 7,713 | 8,098 | (6,871) | 4,975 | 5,968 | ||
| Income tax expense | (400) | (1,368) | (1,084) | (2,124) | (1,515) | (1,021) | ||
| Income (loss) from continuing operations: | 8,040 | 6,345 | 7,014 | (8,995) | 3,460 | 4,947 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 7,014 | (8,995) | 3,460 | 4,947 | |
| Net income (loss): | 8,040 | 6,345 | 7,014 | (8,995) | 3,460 | 4,947 | ||
| Net loss attributable to noncontrolling interest | (18) | (20) | (20) | (21) | (27) | |||
| Other undisclosed net loss attributable to parent | (15) | |||||||
| Net income (loss) available to common stockholders, diluted: | 8,025 | 6,327 | 6,994 | (9,015) | 3,439 | 4,920 | ||
Comprehensive Income ($ in millions)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 8,040 | 6,345 | 7,014 | (8,995) | 3,460 | 4,947 | ||
| Other comprehensive income (loss) | (265) | (13) | 571 | (319) | 1,242 | (156) | ||
| Comprehensive income (loss): | 7,775 | 6,332 | 7,585 | (9,314) | 4,702 | 4,791 | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (15) | (18) | (20) | (20) | (21) | (27) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 7,760 | 6,314 | 7,565 | (9,334) | 4,681 | 4,764 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.